Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome

Hormone and Metabolic Research

Volumn 44, Issue 9, 2012, Pages 694-698

  Glintborg, D ^a   Mumm, H ^a   Ravn, P ^a   Andersen, M ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ACTH test; age; diabetes; insulin resistance; oral glucose tolerance test

Indexed keywords

FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; INSULIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CAUCASIAN; CLINICAL ARTICLE; FEMALE; GROUPS BY AGE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; LABORATORY TEST; NETHERLANDS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TRANSVAGINAL ECHOGRAPHY;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD GLUCOSE; DENMARK; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; METABOLIC DISEASES; METABOLIC SYNDROME X; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PREVALENCE; REPRODUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84864854916     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1304608     Document Type: Article

References (29)

1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril: 2004; 1 19 25
2. Glintborg D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol: 2010; 4 281 296
3. Wild R A, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale H F, Futterweit W, Lobo R, Norman R J, Talbott E, Dumesic D A. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab: 2010; 5 2038 2049
4. Kristensen S L, Ramlau-Hansen C H, Ernst E, Olsen S F, Bonde J P, Vested A, Toft G. A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed? Hum Reprod: 2010; 12 3117 3122
5. Bryhni B, Arnesen E, Jenssen T G. Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study. BMC Endocr Disord: 2010; 21
6. Azziz R, Sanchez L A, Knochenhauer E S, Moran C, Lazenby J, Stephens K C, Taylor K, Boots L R. Androgen excess in women: experience with over 1 000 consecutive patients. J Clin Endocrinol Metab: 2004; 2 453 462 (Pubitemid 38269843)
7. Glintborg D, Hermann A P, Brusgaard K, Hangaard J, Hagen C, Andersen M. Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls. J Clin Endocrinol Metab: 2005; 3 1347 1353 (Pubitemid 40463986)
8. Moran C, Azziz R. The role of the adrenal cortex in polycystic ovary syndrome. Obstet Gynecol Clin North Am: 2001; 1 63 75 (Pubitemid 32242540)
9. Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen J S. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab: 2009; 6 1973 1978
10. Norman R J, Masters L, Milner C R, Wang J X, Davies M J. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod: 2001; 9 1995 1998 (Pubitemid 32916235)
11. Ehrmann D A, Barnes R B, Rosenfield R L, Cavaghan M K, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care: 1999; 1 141 146 (Pubitemid 29028311)
12. Glintborg D, Henriksen J E, Andersen M, Hagen C, Hangaard J, Rasmussen P E, Schousboe K, Hermann A P. Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis. Fertil Steril: 2004; 6 1570 1579 (Pubitemid 39611385)
13. Ferriman D, Gallwey J D. Clinical assessment of body hair growth in women. J Clin Endocrinol: 1961; 1440 1447
14. Salley K E, Wickham E P, Cheang K I, Essah P A, Karjane N W, Nestler J E. POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome A Position Statement of the Androgen Excess Society. J Clin Endocrinol Metab: 2007; 12 4546 4556 (Pubitemid 350223423)
15. Lykkesfeldt G, Bennett P, Lykkesfeldt A E, Micic S, Moller S, Svenstrup B. Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis. Clin Endocrinol (Oxf): 1985; 4 385 393 (Pubitemid 16216758)
16. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab: 2000; 12 4426 4433 (Pubitemid 32157613)
17. Duijkers I J, Klipping C. Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. Gynecol Endocrinol: 2010; 3 152 160
18. Jones G L, Hall J M, Balen A H, Ledger W L. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update: 2008; 1 15 25
19. Janssen O E, Hahn S, Tan S, Benson S, Elsenbruch S. Mood and sexual function in polycystic ovary syndrome. Semin Reprod Med: 2008; 1 45 52
20. Carmina E, Oberfield S E, Lobo R A. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol: 2010; 3 201 205
21. Elting M W, Korsen T J, Rekers-Mombarg L T, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod: 2000; 1 24 28
22. Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Sundstrom-Poromaa I. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up. Fertil Steril: 2011; 96 1271 1274
23. Kumar A, Woods K S, Bartolucci A A, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf): 2005; 6 644 649 (Pubitemid 40825931)
24. Park S J, Goldsmith L T, Weiss G. Age-related changes in the regulation of luteinizing hormone secretion by estrogen in women. Exp Biol Med (Maywood): 2002; 7 455 464
25. Brann D W, Mahesh V B. The aging reproductive neuroendocrine axis. Steroids: 2005; 4 273 283 (Pubitemid 40387382)
26. Chen H, Guo J H, Lu Y C, Ding G L, Yu M K, Tsang L L, Fok K L, Liu X M, Zhang X H, Chung Y W, Huang P, Huang H, Chan H C. Impaired CFTR-Dependent Amplification of FSH-Stimulated Estrogen Production in Cystic Fibrosis and PCOS. J Clin Endocrinol Metab: 2011; Dec 14 [Epub ahead of print]
27. Skalba P, Dabkowska-Huc A, Kazimierczak W, Samojedny A, Samojedny M P, Chelmicki Z. Content of 5-alpha-reductase (type 1 and type 2) mRNA in dermal papillae from the lower abdominal region in women with hirsutism. Clin Exp Dermatol: 2006; 4 564 570 (Pubitemid 43806594)
28. Horton R, Pasupuletti V, Antonipillai I. Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I. Endocrinology: 1993; 2 447 451 (Pubitemid 23238847)
29. Wild R A, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale H F, Futterweit W, Lobo R, Norman R J, Talbott E, Dumesic D A. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Position Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab: 2010; 95 2038 2049